J&J lung cancer initiative will use Optellum’s ‘digital biomarker’ tech
pharmaphorum
AUGUST 26, 2021
UK-based Optellum has developed an AI-powered clinical decision support – called Virtual Nodule Clinic – that it says acts as a “digital biomarker”, looking for signs of cancer in computed tomography (CT) scans. It was approved by the FDA in March, and is starting to roll out in US hospitals.
Let's personalize your content